Abstract:Epidemiologic studies have shown that the female predominance in the morbidity of Idiopathic PAH (pulmonary arterial hypertension) in the world, which suggests a role of female sex hormones in the pathogenesis of PAH. Our previous study demonstrated the contradictory effects of estrogen on pulmonary arterial endothelial cells (PAEC) via BMP (Bone Morphogenetic Protein) signaling depend on cellular oxygen environment. This study is to investigate the mechanism of the contradictory effect of β -estradiol (E2) upon BMP signaling in PAEC. Human and rat PAEC were cultured and the expression of BMPR2, Smad1/5/8, and Id1 were examined under 21%O 2 (normoxic; N) or 1%O 2 (hypoxic; H) condition in the presence of E2. We investigated the effect of estrogen receptor antagonist (ICI 182.780.) and searched for an evidence of binding interaction between estrogen receptor (ER) and Smad. In the presence of E2 (10 −7 M), the expression of BMPR2, phosphorylated Smad (p-Smad)1/5/8 proteins, Id1 mRNA was augmented under N and suppressed under H. We confirmed same phenomena by using Id1 promoter assay. These alterations of BMPR signal expression were inhibited by ICI182.780. An Immunoprecipitation experiment demonstrated a direct binding interaction between ER and p-Smad1/5/8 proteins only under H, whereas estrogen response activity measured by luciferase assay was increased by E2 only under N. In addition, HIF-1 α augmentation by cobalt chloride suppressed BMP signaling, whereas HIF-1 α inhibition by YC-1 augmented those expression. By inhibiting de novo synthesis by administration of cycloheximide, p-Smad1/5/8 were suppressed under N, but could not change under H. We demonstrated that the alteration of BMP signaling in PAEC under different O 2 condition was associated with HIF-1 α expression and the presence of E2. This alteration may also relate to an interaction between BMP signaling and receptor-mediated estrogen pathway under hypoxia, and to de novo synthesis under normoxia. Our observations provide the new mechanism how sex hormone affects on BMP signaling, a key signal pathway for PAH, which can offer novel therapeutic targets in the treatment of PAH.

Estrogen Oppositely Regulates Pulmonary Hypertension via METTL3/PFKFB3 Under Normoxia and Hypoxia

Epigenetic Regulation and Its Therapeutic Potential in Pulmonary Hypertension

Abstract 14566: the Role of Eosinophils in Pulmonary Hypertension

Epigenetic Modulation in the Initiation and Progression of Pulmonary Hypertension.

Estrogen and Testosterone in Concert with EFNB3 Regulate Vascular Smooth Muscle Cell Contractility and Blood Pressure

Upregulation of SIRT1 and FOXO3a Contributes to The Protective Role of Estrogen on HPH in Rats

Abstract 4919: Contradictive Estrogen Effects on BMP Signaling in Pulmonary Artery Depend on Oxygen Concentration

Overexpressed pigment epithelium-derived factor alleviates pulmonary hypertension in two rat models induced by monocrotaline and SU5416/hypoxia

Role of <scp>miR</scp>‐21‐5p/<scp>FilGAP</scp> axis in estradiol alleviating the progression of monocrotaline‐induced pulmonary hypertension

METTL3-Driven m6A Modification of RBPJ Promotes Vascular Remodeling in Pulmonary Hypertension

PFKFB3-mediated Endothelial Glycolysis Promotes Pulmonary Hypertension.

Role of miR-21-5p/FilGAP axis in estradiol alleviating the progression of monocrotaline-induced pulmonary hypertension

Role of G protein‐coupled estrogen receptors in pulmonary hypertension

PPARγ/ETV2 axis regulates endothelial‐to‐mesenchymal transition in pulmonary hypertension

EP3 Receptor Deficiency Attenuates Pulmonary Hypertension Through Suppression of Rho/TGF-β1 Signaling

Abstract 306: Endothelial 6-Phosphofructo-2-Kinase/Fructose-2,6-Bisphosphatase, Isoform 3 (PFKFB3) Deficiency Inhibits Hypoxia-Induced Pulmonary Hypertension in Mice

Role of 20-Hydroxyeicosatetraenoic Acid in Pulmonary Hypertension and Proliferation of Pulmonary Arterial Smooth Muscle Cells.

Endothelial 6-Phosphofructo-2-Kinase/Fructose-2,6-Bisphosphatase, Isoform 3 (PFKFB3) Deficiency Inhibits Hypoxia-Induced Pulmonary Hypertension in Mice

The Serotonin Transporter Promotes a Pathological Estrogen Metabolic Pathway in Pulmonary Hypertension via Cytochrome P450 1B1

The M6a Methyltransferase METTL3 Promotes Hypoxic Pulmonary Arterial Hypertension Via Targeting PTEN

Dual PEDF and HGF Overexpression: A New Therapy for Pulmonary Hypertension